Skip to main content Skip to main navigation menu Skip to site footer
Original article
Austral J. Vet. Sci.
Vol 49, 99-104 (2017)

Cell block sensitivity for immunohistochemical detection of cytokeratin 5, oestrogen and progesterone receptors in canine primary mammary carcinoma

1 Department of Pathology, Botucatu Medical School, Universidade Estadual Paulista, São Paulo, Brazil.
2 Department of Veterinary Clinics, School of Veterinary Medicine and Animal Science, Universidade Estadual Paulista, São Paulo, Brazil.
3 Department of Pathology, Botucatu Medical School, Universidade Estadual Paulista, São Paulo, Brazil; Department of Pathology, Barretos Cancer Hospital and Faculty of Health Sciences Barretos Dr Paulo Prata, Barretos, Brazil.
4 Department of Veterinary Clinics, School of Veterinary Medicine and Animal Science, Universidade Estadual Paulista, São Paulo, Brazil; Veterinary Pathology Research Group, Faculty of Agricultural Sciences, Universidad de Caldas, Manizales, Colombia; GIDIMEVETZ, Universidad Pedagógica y Tecnológica de Colombia, Tunja-Boyacá, Colombia.
5 Department of Pathology, Botucatu Medical School, Universidade Estadual Paulista, São Paulo, Brazil; Department of Veterinary Clinics, School of Veterinary Medicine and Animal Science, Universidade Estadual Paulista, São Paulo, Brazil.
Keywords: cytoinclusion histopathological immunohistochemistry tumor

Submitted: 2016-08-15

Accepted: 2017-01-05

Published: 2017-05-01

*Corresponding author:
maomontoya53@yahoo.es

How to Cite

Silveira, T. L., Campos, L. M., Dufloth, R. M., Miot, H. A., Fêo, H. B., Montoya, L. M., & Rocha, N. S. (2017). Cell block sensitivity for immunohistochemical detection of cytokeratin 5, oestrogen and progesterone receptors in canine primary mammary carcinoma. Austral Journal of Veterinary Sciences, 49(2), 99–104. https://doi.org/10.4067/S0719-81322017000200099

Abstract

Mammary carcinomas are relatively common ailments among female canines aged around 10 years old, presenting an important morbidity with an average survival of five years. The cytoinclusion technique is frequently employed in human medicine as the investigative method of choice as it quickly provides resources for the determination of the correct therapeutic response, however, the effectiveness of the technique in canines remains understudied in veterinary medicine. This study aims at evaluating the degree of correlation with immunohistochemical marking for cytokeratin 5 (CK5), oestrogen and progesterone receptors (ER and PR) between the cytoinclusion and the histopathology technique in mammary carcinomas. Twenty-five samples of mammary carcinoma, both for the cytoinclusion and histopathological techniques were submitted for histological processing; microscope slides were created for hematoxylin-eosin (HE) staining and the immunohistochemical technique (IHC) was assessed for the ER, PR and CK5 receptors. Through the HE staining, we reached a concordance rate of 100% between the cytoinclusion and the histopathological analysis in the diagnosis of carcinomas. The immunohistochemical assay presented sensitivity of 85.71%, 95.45% and 100% and Cohen’s kappa of 0.78, 0.84 and 0.95 for ER, PR and CK5, respectively, as well as 100% specificity and P<0.01 for all three markers. Therefore, cytoinclusion represents an accessible, fast and low-cost method, offering high sensitivity for the cytomorphological and immunohistochemical diagnosis of mammary carcinoma in female canines.

Downloads

Download data is not yet available.

References

  1. Bueno AS, Viero RM, Soares CT. 2013. Fine needle aspirate cell blocks are reliable for detection of hormone receptors and HER-2 by immunohistochemistry in breast carcinoma. Cytopathology 24, 26-32.
  2. Cassali GD. 2011. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Braz J Vet Pathol 4, 153-180.
  3. Constantian HM, de Girolami E. 1973. Urothelial tumors detected by cytology: New cell block technique. J Urol 109, 304-307.
  4. Crapanzano JP, Heymann JJ, Monaco S, Nassar A, Saqi A. 2014. The state of cell block variation and satisfaction in the era of molecular diagnostics and personalized medicine. Cyto Journal, 11-17.
  5. De Las Mulas JM, Ordás J, Millán MY, Chacón F, De Lara M, et al. 2004. Immunohistochemical expression of estrogen receptor ß in normal and tumoral canine mammary glands. Vet Pathol 41, 269-272.
  6. Else RW, Hannant D. 1979. Some epidemiological aspects of mammary neoplasia in the bitch. Vet Rec 104, 296-304.
  7. Ferreira I, Bulla C, Baumgartner W, Bagnato VS, Rocha NS. 2013. Quantitative analysis of photodynamic therapy effects in rat mammary tumor vascular density using Image-Pro Plus Software. Open Journal of Veterinary Medicine 3, 259-262.
  8. Figueiroa FC, Salgado BS, Monteiro LN, Rocha RM, Domingues MAC, et al. 2012. Immunoexpression of cathepsin D and S100A4 protein and their molecular subtyptes in canine mammary carcinomas. Open Journal of Veterinary Medicine 2, 163-169.
  9. Fowler LJ, Lachar WA. 2008. Application of immunohistochemistry to cytology. Arch Pathol Lab Med 132, 373-83.
  10. Goldschmidt M, Peña L, Rasotto R, Zappulli V. 2011. Classification and grading of canine mammary tumors. Vet Pathol 48, 117-131.
  11. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, et al. 2010. American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer (Unabridged Version). Arch Pathol Lab Med 134, 48-72.
  12. Horta RS, Costa MP, Lavalle GE, Araújo RB, Cassali GD. 2012. Fatores prognósticos e preditivos dos tumores caninos definidos com o auxílio da imuno-histoquímica. Cienc Rural 42, 1033-1039.
  13. INCA-Brasil (Instituto Nacional do Câncer). 2011. Cancer incidence in Brazil estimate/2012. INCA, Rio de Janeiro, Brazil.
  14. Kamiguchi IE, Moreira IM, Da Silva Trindade F, Zahn FS, Hataka A, et al. 2016. Mammary neoplasms in female dogs: Identification of cytopathological criteria for malignancy. J Cytol Histol 7, 392.
  15. Lindeman NI, Cagle PT, Beasley MB, Chitale DA, Dacic A, et al. 2013. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol 8, 823-859.
  16. Matos I, Dufloth R, Alvarenga M, Zeferino LC, Schmitt F. 2005. p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas. Virchows Archiv 447, 688-694.
  17. Misdorp W, Else RW, Hellmén E, Lipscomb TP. 1999. Histological classification of the mammary tumours of the dog and the cat. In: World Health Organization. International histological classification of tumours of domestic animals. 2nd series. Vol.7. Washington, DC, USA, Pp 59.
  18. Moulton JE. 1990. Tumors of the mammary gland. In: Moulton JE (ed). Tumors in domestic animals. University of California Press, Los Angeles, Pp 518-552.
  19. Mulder AB, Blom NR, van der Meer J, Ruud HM, Smit JW. 1997. A simple procedure for in situ immunolabeling embedding and sectioning of layers of cultured endothelial and smooth muscle cells for both light and electron microscopy. Biotech Histochem 72, 45-48.
  20. Nguyen F, Abadie J, Loussouarn D, Ibisch C, Rieder N, et al. 2011. Spontaneous canine mammary carcinomas as a model of human triple-negative breast câncer. Cancer Res (8 Supplement) 71, LB-46.
  21. Paiva MB, Gouveia GM, Beserra HEO, Silva JM, Luvizotto MCR. 2011a . Use of cellblock method for neoplastic diagnosis in veterinary medicine. In: Anais do XV Encontro Nacional de Patologia Veterinária (ENAPAVE), Goiânia, Brazil. Paiva MB, Gouveia GM, Luvizotto MCR. 2011b. Utilização de marcador orgânico na técnica de cito inclusão com gel de agarose. Vet Zootec 18, 76.
  22. Ramalho LNZ, Ribeiro-Silva A, Cassali GD, Zucoloto S. 2006. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms. Vet Pathol 43, 424-429.
  23. Raskin RE, Meyer DJ. 2010. Atlas de Citologia de Cães e Gatos. 1st ed. Ed Rocca, São Paulo, Brasil.
  24. Sanchez N, Selvaggi SM. 2006. Utility of cell blocks in the diagnosis of thyroid aspirates diagnostic. Cytopathology 34, 89-92.
  25. Siegel R, Naishadham D, Jemal A. 2012. Cancer statistics-CA-Cancer. J Clin 62, 10-29.
  26. Terra EM, Rodrigues MP, Magalhães GM, Costa MT, Amorim RL, et al. 2012. Immunohistochemical expression of p53 and p63 in adenomas and carcinomas of canine mammary glands. OJVM 2, 21-24.
  27. Yamashita H, Yando Y, Nishio M, Zhang Z, Hamaguchi M, et al. 2006. Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer. Breast Cancer 13, 74-83.
  28. Zakhour H, Wells C. 1999. Diagnostic cytopathology of the breast. Churchill Livingstone, London, UK. Zanoni DS, Grandi F, Rocha NS. 2012. Use of the agarose cell block technique in veterinary diagnostic cytopathology: an “old and forgotten” method. Vet Clin Pathol 41, 307-310.
  29. Zanoni DS, Kleeb SR, Xavier JG. 2013. Employment of cell block of agarose as additional method in the cytological diagnosis of canine mammary tumors. Cienc Rural 43, 489-495.
  30. Zuccari DAPC, Santana AE, Rocha NS. 2001. Correlação entre a citologia aspirativa por agulha fina e a histologia no diagnóstico de tumores mamários de cadelas. Braz J Vet Res Anim Sci 38, 38-41.
  31. Zuccari DAPC, Berton CR, Terzian ACB, Ruiz CM. 2008. Fatores prognósticos e preditivos nas neoplasias mamárias-importância dos marcadores imuno-histoquímicos nas espécies humana e canina-estudo comparativo. Arq Ciênc Saúde 15, 189-198.

Make a Submission

Journal Metrics (2023) & Ranking

Impact Factor
0.5 (2024)
5 years Impact Factor
0.8
JCR Quartile
Q4
JIF Rank
134/170 (Veterinary Sciences)
SJR (2024)
0.244
SNIP (2024)
0.35

 


 

SCImago Journal & Country Rank

Indexed in




Publisher

Keywords